Primary atypical teratoid/rhabdoid tumors (AT/RTs) in the spinal canal are rare central nervous system (CNS) neoplasms that are challenging to diagnose and treat. To date, there has been no standard treatment regimen for these challenging malignant tumors. Thus, we conducted this research to explore potential prognostic factors and feasible treatment modalities for improving the prognosis of these tumors. Articles were retrieved from the PubMed, MEDLINE, and Embase databases, using the keywords “atypical teratoid/rhabdoid tumor,” “rhabdoid tumor,” “spine,” “spinal,” “spinal neoplasm”, and “spinal cord neoplasm.” All eligible cases demonstrated SMARCB1-deficient expression validated by pathological examination. We collected and analyzed data related to clinical presentation, radiological features, pathological characteristics, treatment modalities and prognosis via Kaplan-Meier and Cox regression analyses. Thirty-six articles comprising 58 spinal AT/RT patients were included in the study. The median progression-free survival (PFS) and overall survival (OS) were 18 and 22 months, respectively. Kaplan-Meier analysis demonstrated significant survival improvements for OS in the nonmetastasis, male, radiotherapy and intrathecal chemotherapy groups as well as for PFS in the chemotherapy and radiotherapy groups. Multivariate analysis revealed that chemotherapy and radiotherapy were prognostic factors for improved PFS, and that intrathecal chemotherapy reduced the risk of mortality. Spinal AT/RTs are uncommon malignant entities with a dismal survival rate. Although our review is limited by variability between cases, there is some evidence revealing potential risk factors and the importance of systematic chemotherapy, intrathecal chemotherapy and radiotherapy in spinal AT/RT treatment modalities.
Citations
Citations to this article as recorded by
Pediatric Spinal Atypical Teratoid Rhabdoid Tumor: Recent Advances in Biology and Management Options Ruby Siada, Kaushik Banerjee, Payal Malhotra, Mohannad Ibrahim, Daniel C. Moreira, John R. Prensner, Santhosh A. Upadhyaya Cancers.2026; 18(7): 1171. CrossRef
Right Upper Lobe Pulmonary Spindle Cell Neoplasm With Rhabdoid Differentiation and Spinal Canal Invasion in a 19‐Year‐Old Female: A Case Report Quang Dai La, Aiman Baloch, Sobia Ahmed, Muhammad Ayub, Shanmukh Bachhu, Eric Teng, Hafsa Qayyum, Nam T. Nguyen Clinical Case Reports.2026;[Epub] CrossRef
Influence of remazolam and propofol on intraoperative neurophysiological monitoring during spinal surgery: A prospective randomized study Ying Zhou, Hai-Fang Li, Yan-Ping Li, Ya-Jing Niu, Qi-Chao Su, Zhi-Hui Ma Medicine.2025; 104(37): e43943. CrossRef
Histogenesis of Atypical Teratoid Rhabdoid Tumors: Anatomical and Embryological Perspectives Tadanori Tomita Cancers.2025; 18(1): 8. CrossRef
Traumatic spinal cord injury (SCI) disrupts the spinal cord vasculature resulting in ischemia, amplification of the secondary injury cascade and exacerbation of neural tissue loss. Restoring functional integrity of the microvasculature to prevent neural loss and to promote neural repair is an important challenge and opportunity in SCI research. Herein, we summarize the course of vascular injury and repair following SCI and give a comprehensive overview of current experimental therapeutic approaches targeting spinal cord microvasculature to diminish ischemia and thereby facilitate neural repair and regeneration. A systematic review of the published literature on therapeutic approaches to promote vascular repair after experimental SCI was performed using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) standards. The MEDLINE databases PubMed, Embase, and OVID MEDLINE were searched using the keywords “spinal cord injury,” “angiogenesis,” “angiogenesis inducing agents,” “tissue engineering,” and “rodent subjects.” A total of 111 studies were identified through the search. Five main therapeutic approaches to diminish hypoxia-ischemia and promote vascular repair were identified as (1) the application of angiogenic factors, (2) genetic engineering, (3) physical stimulation, (4) cell transplantation, and (5) biomaterials carrying various factor delivery. There are different therapeutic approaches with the potential to diminish hypoxia-ischemia and promote vascular repair after experimental SCI. Of note, combinatorial approaches using implanted biomaterials and angiogenic factor delivery appear promising for clinical translation.
Citations
Citations to this article as recorded by
Synergistic aligned neuronal and vascular growth inside 3D-PEG-Anisogels utilizing a triple-co-culture Céline Bastard, Philip Pietryszek, Hela Uplegger, Matthias Mork, Jose Luis Gerardo Nava, Tamás Haraszti, Laura De Laporte Materials Today Bio.2026; 36: 102737. CrossRef
Optimizing deferoxamine delivery through the skin for pressure ulcers Katharina S. Berryman, Maria Gracia Mora Pinos, Amy Skarsfeldt, Lulejeta Latifi, Pedro Mora Pinos, Kellen Chen, Geoffrey C. Gurtner Expert Opinion on Drug Delivery.2026; 23(4): 621. CrossRef
Spatiotemporal PET imaging of P2X7R-driven neuroinflammation using [18F]GSK1482160 after experimental acute spinal cord injury in mice Jiaxing Shi, Kun Wang, Yuyi Hou, Sirui Wu, Yifan Qiu, Xiang Liu, Lihua Huang, Shiyanjin Zhang, Hongjun Jin, Hai Lu Brain, Behavior, and Immunity.2026; 134: 106279. CrossRef
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy Shuyu Xu, Tianjiao Zhang, Yang Song, Mengxin Wang, Ruiqi Wu, Mofan Li, Haonan Wang, Xinxin Xie, Qingfeng Chen, Xiaotu Ma, Xiaolong Liang Nature Biotechnology.2026;[Epub] CrossRef
Spinal Cord Blood Perfusion Deficit is Associated with Clinical Impairment after Spinal Cord Injury Anna Lebret, Sabina Frese, Simon Lévy, Armin Curt, Virginie Callot, Patrick Freund, Maryam Seif Journal of Neurotrauma.2025; 42(3-4): 280. CrossRef
Identification of a Therapeutic Window for Neurovascular Unit Repair after Experimental Spinal Cord Injury Vanessa Hubertus, Lea Meyer, Lilly Waldmann, Laurens Roolfs, Nima Taheri, Katharina Kersting, Emily von Bronewski, Melina Nieminen-Kelhä, Irina Kremenetskaia, Christian Uhl, Kim C. Fiedler, Jan-Erik Ode, Andre Rex, Harald Prüß, Asylkhan Rakhymzhan, Anja E Journal of Neurotrauma.2025; 42(3-4): 212. CrossRef
Analysis of the spatiotemporal dynamics of vascular injury and regeneration following experimental Spinal Cord Injury Christian J. Entenmann, Emily J. von Bronewski, Lilly Waldmann, Lea Meyer, Katharina Kersting, Laurens T. Roolfs, Lasse M. Schleker, Melina Nieminen-Kelhä, Irina Kremenetskaia, Frank L. Heppner, Michael G. Fehlings, Peter Vajkoczy, Vanessa Hubertus Brain and Spine.2025; 5: 104191. CrossRef
AO Spine Clinical Practice Recommendations for the Surgical Management of Acute Traumatic Spinal Cord Injury: Contemporary Concepts Vanessa Hubertus, Jetan H. Badhiwala, Nader Hejrati, Aria Nouri, Paula V. Ter Wengel, Farzin Farahbakhsh, Christoph Hofstetter, Chris J. Neal, Mario Ganau, Nitin Agarwal, Paul Arnold, Paul Koljonen, James Harrop, Bizhan Aarabi, James Guest, Ricardo Rodrig Global Spine Journal.2025; 15(8): 3572. CrossRef
Quercetin promotes angiogenesis and protects the blood-spinal cord barrier structure after spinal cord injury by targeting the PI3K/Akt signaling pathway Xinfang Liu, Xuhua Liu, Sidong Luo, Di Chen, Jinbo Lin, Man Xiong, Lei Yang, Kaifan Li, Dawei Sun, Lina Wei, Sheng Luo, Yeyang Wang Journal of Translational Medicine.2025;[Epub] CrossRef
Stem cell therapy for locomotion recovery and neuropathic pain alleviation in spinal cord injury: an umbrella review and meta-analysis Amir Azimi, Amirmohammad Toloui, Mohammadhossein Mozafarybazargany, Mohammad Kiah, Hamed Zarei, Parsa Paridari, Sajjad Jabermoradi, Donya Pourkand, Hamzah Adel Ramawad, Alexander R. Vaccaro, Mostafa Hosseini, Mahmoud Yousefifard, Vafa Rahimi-Movaghar Spinal Cord.2025; 63(8): 393. CrossRef
Peptide-conjugated aligned silk fiber simultaneously promotes angiogenesis and neurogenesis for spinal cord injury therapy Ke Jian, Chaoyong He, Ziqiang Wang, Yajun Li, Can Zhang, Liyang Shi, Jianwu Dai Chemical Engineering Journal.2025; 523: 168679. CrossRef
Neurovascular dynamics in the spinal cord from development to pathophysiology Carmen Ruiz de Almodovar, Sebastian Dupraz, Dario Bonanomi Neuron.2025; 113(24): 4134. CrossRef
Endothelial ephrin-B2 knockdown increases post-traumatic disruption of the blood-spinal cord barrier following spinal cord injury Katharina Kersting, Emily J. von Bronewski, Laurens T. Roolfs, Lea Meyer, Lilly Waldmann, Melina Nieminen-Kelhä, Irina Kremenetskaia, Anja Nitzsche, Andre Rex, Harald Prüß, Ralf Adams, Frank L. Heppner, Michael G. Fehlings, Peter Vajkoczy, Vanessa Hubertu Neurobiology of Disease.2025; 217: 107168. CrossRef
A Comprehensive Overview of Spinal Cord Injury (SCI) Experimental Models Modinat Olushanu Premier Journal of Neuroscience.2025;[Epub] CrossRef
AAV-mediated VEGFA overexpression promotes angiogenesis and recovery of locomotor function following spinal cord injury via PI3K/Akt signaling Xin Miao, Junqing Lin, Ang Li, Tao Gao, Tiexin Liu, Junjie Shen, Yi Sun, Jiabao Wei, Bingbo Bao, Xianyou Zheng Experimental Neurology.2024; 375: 114739. CrossRef
AO Spine/Praxis Clinical Practice Guidelines for the Management of Acute Spinal Cord Injury: An Introduction to a Focus Issue Brian K. Kwon, Lindsay A. Tetreault, Nathan Evaniew, Andrea C. Skelly, Michael G. Fehlings Global Spine Journal.2024; 14(3_suppl): 5S. CrossRef
Intranasal delivery of small extracellular vesicles from specific subpopulation of mesenchymal stem cells mitigates traumatic spinal cord injury Yi Sun, Jinyun Zhao, Quanbo Liu, Yan Xu, Yiming Qin, Rundong He, Lifu Zheng, Yong Xie, Chengjun Li, Tianding Wu, Yong Cao, Chunyue Duan, Hongbin Lu, Jianzhong Hu Journal of Controlled Release.2024; 369: 335. CrossRef
Spinal Cord Injury Management Based on Microglia-Targeting Therapies Thomas Gabriel Schreiner, Oliver Daniel Schreiner, Romeo Cristian Ciobanu Journal of Clinical Medicine.2024; 13(10): 2773. CrossRef
Stem Cell and Regenerative Therapies for the Treatment of Osteoporotic Vertebral Compression Fractures Songzi Zhang, Yunhwan Lee, Yanting Liu, Yerin Yu, Inbo Han International Journal of Molecular Sciences.2024; 25(9): 4979. CrossRef
Therapeutic Transplantation of Human Central Nervous System Organoids for Neural Reconstruction Sung Jun Hong, Minsung Bock, Songzi Zhang, Seong Bae An, Inbo Han International Journal of Molecular Sciences.2024; 25(15): 8540. CrossRef
Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair Daniel Youngsuk Kim, Yanting Liu, Gyubin Kim, Seong Bae An, Inbo Han International Journal of Molecular Sciences.2024; 25(17): 9592. CrossRef
p53/HIF-1α regulates neuronal aging and autophagy in spinal cord ischemia/reperfusion injury Xingzhen Liu, Jia Wang, Kangping Shen, Wenjie Jin Mechanisms of Ageing and Development.2024; 222: 112000. CrossRef
Co-Administration of Resolvin D1 and Peripheral Nerve-Derived Stem Cell Spheroids as a Therapeutic Strategy in a Rat Model of Spinal Cord Injury Seung-Young Jeong, Hye-Lan Lee, SungWon Wee, HyeYeong Lee, GwangYong Hwang, SaeYeon Hwang, SolLip Yoon, Young-Il Yang, Inbo Han, Keung-Nyun Kim International Journal of Molecular Sciences.2023; 24(13): 10971. CrossRef
The Importance of Vascular Repair as the First Step in Spinal Cord Injury Treatment: Commentary on “Therapeutic Approaches Targeting Vascular Repair After Experimental Spinal Cord Injury: A Systematic Review of the Literature” Kyoung-Tae Kim Neurospine.2022; 19(4): 976. CrossRef
Acute spinal cord injury (SCI) is devastating for patients and their caretakers and has an annual incidence of 20–50 per million people. Following initial assessment with appropriate physical examination and imaging, patients who are deemed surgical candidates should undergo decompression with stabilization. Earlier intervention can improve neurological recovery in the post-operative period while allowing earlier mobilization. Optimized medical management is paramount to improve outcomes. Emerging strategies for managing SCI in the acute period stem from an evolving understanding of the pathophysiology of the injury. General areas of focus include ischemia prevention, reduction of secondary injury due to inflammation, modulation of the cytotoxic and immune response, and promotion of cellular regeneration. In this article, we review established, emerging, and novel experimental therapies. Continued translational research on these methods will improve the feasibility of bench-to-bedside innovations in treating patients with acute SCI.
Citations
Citations to this article as recorded by
The role of autophagy in spinal cord injury: Mechanisms, crosstalk, and therapeutic strategies Rui Wang, Zhen Niu, Runze Tian, Aini Chen, Huangmei Liao, Rui Kuang, Ying Feng, Guangyu Chin, Jiesheng Xie, Ping Zhu, Chi Teng Vong, Ge Li Neural Regeneration Research.2026; 21(6): 2110. CrossRef
The Interplay Between Neuromodulation and Stem Cell Therapy for Sensory-Motor Neuroplasticity After Spinal Cord Injury: A Perspective View Anthony Yousak, Kaci Ann Jose, Ashraf S. Gorgey Journal of Clinical Medicine.2026; 15(2): 879. CrossRef
Automated active learning to optimize hydrogel drug release profiles Eugene Cheong, D. Christopher Radford, Adam J. Gormley Journal of Controlled Release.2026; 391: 114602. CrossRef
Andrograpanin attenuates secondary neuroinflammation after spinal cord injury by modulating microglial glycolysis via HIF-1α Bin Dai, Xintian Ding, Kaichen Huang, Jiahao Ruan, Jiafeng Peng, Hongxing Zhang, Dapeng Li International Immunopharmacology.2026; 182: 116796. CrossRef
Autonomic dysreflexia: the concealed killer behind recurrent cerebral hemorrhage in spinal cord injury—a case report with management insights Nengzhang Tang, Bi'e Zheng, Jun Ni, Yimiao Xie, Lifang Zhang, Qiong Han, Limin Sun Frontiers in Neuroscience.2026;[Epub] CrossRef
Roflumilast inhibits neuronal ferroptosis via AMPK/Nrf2/HO-1 signaling and promotes motor function recovery after spinal cord injury in rats YaoNan Han, XingTong Wang, DeShui Yu Cellular Signalling.2025; 134: 111930. CrossRef
Bibliometric Analysis of Exosome Research in Spinal Cord Injury (2000–May 2024). Trends, Collaborations, and Emerging Insights Zhihua Wang, Hangchuan Bi, Denghui Li, Wan Zhang, Chao Wang, Jianyi Yang, Xianglin Shen, Rongji Yan, Fei He, Hao Duan Drug Design, Development and Therapy.2025; Volume 19: 6829. CrossRef
Therapeutic potential of luteolin-loaded poly(lactic-co-glycolic acid)/modified magnesium hydroxide microsphere in functional thermosensitive hydrogel for treating neuropathic pain So-Yeon Park, Joon Hyuk Jung, Da-Seul Kim, Jun-Kyu Lee, Byeong Gwan Song, Hae Eun Shin, Ji-Won Jung, Seung-Woon Baek, Seungkwon You, Inbo Han, Dong Keun Han Journal of Tissue Engineering.2024;[Epub] CrossRef
Morphogenetic Designs, and Disease Models in Central Nervous System Organoids Minsung Bock, Sung Jun Hong, Songzi Zhang, Yerin Yu, Somin Lee, Haeeun Shin, Byung Hyune Choi, Inbo Han International Journal of Molecular Sciences.2024; 25(14): 7750. CrossRef
Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair Daniel Youngsuk Kim, Yanting Liu, Gyubin Kim, Seong Bae An, Inbo Han International Journal of Molecular Sciences.2024; 25(17): 9592. CrossRef
Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury Abhishek Roy, Santimoy Sen, Rudradip Das, Amit Shard, Hemant Kumar Neurospine.2024; 21(3): 878. CrossRef
Minocycline as Potential Neuroprotector through Neuroinflammation Halting Mechanism in Spinal Cord Injury: Literature Review Kevin Tjandra Neurologico Spinale Medico Chirurgico.2024; 7(2): 69. CrossRef
Edema after CNS Trauma: A Focus on Spinal Cord Injury Mostafa Seblani, Patrick Decherchi, Jean-Michel Brezun International Journal of Molecular Sciences.2023; 24(8): 7159. CrossRef
Recent updates in autonomic research: advances in the understanding of autonomic dysfunction after spinal cord injury Vera-Ellen M. Lucci Clinical Autonomic Research.2023; 33(2): 83. CrossRef
Commentary on “Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury” Jeffrey Luo, Joshua B. Stein, Ki-Bum Lee Neurospine.2023; 20(2): 449. CrossRef
Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury Lahanya Guha, Nidhi Singh, Hemant Kumar Neurospine.2023; 20(2): 430. CrossRef
Commentary on “Established and Emerging Therapies in Acute Spinal Cord Injury” Lingbo Kong Neurospine.2022; 19(2): 297. CrossRef
A Nomogram Model for Prediction of Tracheostomy in Patients With Traumatic Cervical Spinal Cord Injury Yunbo Jian, Dawei Sun, Zhengfeng Zhang Neurospine.2022; 19(4): 1084. CrossRef
Therapeutic Approaches Targeting Vascular Repair After Experimental Spinal Cord Injury: A Systematic Review of the Literature Laurens Roolfs, Vanessa Hubertus, Jacob Spinnen, Lennard K. Shopperly, Michael G. Fehlings, Peter Vajkoczy Neurospine.2022; 19(4): 961. CrossRef
First
Prev
